If you have heard “sema” in a conversation and wondered what everyone else seems to know, you can start here. Semaglutide is a prescription medicine in the GLP-1 receptor agonist family. Different products containing it have different approved uses and instructions.
The first useful question is not how quickly someone else lost weight. It is which product a clinician is considering for you, for what purpose, and how that fits your health history. You do not need to arrive with those answers already worked out.
One thing to keep with you
Get the exact product name and the reason it is being considered before comparing someone else’s experience.
The ingredient and the product are different details
Semaglutide is the active ingredient; a brand and formulation identify a particular medicine. Current Wegovy prescribing information includes both injections and tablets, with product-specific indications and directions. Other semaglutide brands have their own labels.
That is why saying “I take semaglutide” does not give another person enough information to copy the instructions. The pill and injection comparison explains the practical differences without turning them into a do-it-yourself switching plan.
Checked with: Wegovy: current prescribing information · MedlinePlus: GLP-1 medicines
What belongs in the appointment
Tell the clinician about your goals, medical history, other medicines, previous treatment, and any concerns about eating, side effects, or cost. A clinical assessment should consider suitability and alternatives rather than treating an online purchase as automatic approval.
Weight-management medication is usually part of continuing care that also addresses nutrition, activity, and health needs. Our safety guide lists topics to raise, including important conditions and other medicines that can affect the plan.
Checked with: NIDDK: prescription weight-management medicines · Wegovy: current prescribing information
Check whether the offer is compounded
A compounded preparation is not FDA-approved and should not be described as an FDA-approved generic version of a brand. FDA says compounded GLP-1 products should be used only when a patient’s medical needs cannot be met by an approved drug.
The compounding explanation covers the current context, including why an old shortage does not mean unrestricted ongoing availability. A reassuring website or a familiar ingredient does not answer the product-quality and legal requirements for a specific prescription.
Checked with: FDA: concerns about unapproved GLP-1 products · FDA: compounding policy after supply stabilization · FDA: compounding questions and answers
Think past the first delivery
Before enrolling, find out who reviews side effects, how refills are handled, what follow-up costs, and how you can reach a clinician. A first-month promotion can look different from the long-term bill.
Read the cost guide and care reviews, then use the cost planner with an actual quote. These pages help organize the questions; your clinician and pharmacist remain the people to explain the treatment and your prescription.
Checked with: Ro: current program pricing · NovoCare: Wegovy pharmacy offer · FDA: checking online pharmacies
Where we checked the facts
- Wegovy: current prescribing information
June 2026 label includes oral and injectable formulations with product-specific uses and instructions. Do not apply one formulation’s directions to another.
- MedlinePlus: GLP-1 medicines
General patient education about the medicine class, not individual eligibility advice.
- NIDDK: prescription weight-management medicines
Background about clinical assessment and ongoing care; current product label controls newer formulation details.
- FDA: concerns about unapproved GLP-1 products
Current concerns include unapproved products, salt forms and adverse events. Compounding is not equivalent to generic approval.
- FDA: compounding policy after supply stabilization
Semaglutide injection shortage resolved in February 2025. Old shortage exemptions do not establish unrestricted present-day access.
- FDA: compounding questions and answers
Compounded drugs are not FDA-approved.
- Ro: current program pricing
Membership and medication are separate charges. $39 introductory membership; $149 ongoing monthly or lower prepaid equivalents, subject to terms.
- NovoCare: Wegovy pharmacy offer
Manufacturer access and pricing terms checked September 23, 2026. Formulation, strength, eligibility and offer period affect cost.
- FDA: checking online pharmacies
Use official licensing and pharmacy checks; a review site is not a pharmacy auditor.
